India has developed its first indigenous antibiotic, Naphthromycin

• India has developed its first indigenous antibiotic, naphthromycin.

• Naphthromycin is effective against drug-resistant respiratory infections.

• This antibiotic is particularly beneficial for cancer patients and individuals with uncontrolled diabetes.

• Naphthromycin is the first molecule completely designed, developed, and clinically tested in India.

• The drug has been developed in collaboration between the Department of Biotechnology and private pharmaceutical company Wockhardt.

• Dr. Jitendra Singh described this as a perfect example of successful industry-academia partnerships accelerating India's biopharmaceutical development.

• The Minister inaugurated a three-day workshop on "Use of Artificial Intelligence for Multi-Omics Data Integration and Analysis."